Cargando…
Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
INTRODUCTION: Of the nearly 1.4 million new cases of breast cancer diagnosed each year, a large proportion is characterized as hormone receptor negative, lacking estrogen receptors (ER) and/or progesterone receptors (PR). Patients with receptor-negative tumors do not respond to current steroid hormo...
Autores principales: | Wiebe, John P, Zhang, Guihua, Welch, Ian, Cadieux-Pitre, Heather-Anne T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706910/ https://www.ncbi.nlm.nih.gov/pubmed/25927181 http://dx.doi.org/10.1186/bcr3422 |
Ejemplares similares
-
The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women
por: Williams, Andrew E, et al.
Publicado: (2002) -
Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
por: Zhou, Li, et al.
Publicado: (2017) -
Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015) -
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013) -
RIME proteomics of estrogen and progesterone receptors in breast cancer
por: D’Santos, Clive, et al.
Publicado: (2015)